In 1999, I successfully negotiated a worldwide exclusive right to a new discovery from Stanford University that used a small molecular isomer of –S nicotine to produce the growth of new blood vessels in blood-starved tissues (angiogenesis).  I designed, developed, and patented a process for coating vascular stents with anti-restenosis drugs. All technologies have been successful to date. Over the next 8 years, I raised over $20 million dollars for business and technological development.

1985-1996 American BioMed, Inc. (NASDAQ-ABMI).

 

American Biomed, Inc, The Woodlands, Texas.

Founded the company initially as a medical device-consulting firm, which carried out consulting contracts with such companies as Cook Urological, Baxter International, C.R. Bard and others, and expanded it to a NASDAQ public company in l992, raising over $10 million dollars.  Designed and developed 10 new medical products, which received patents, and submitted 3 medical devices to FDA under Reg 510(k).  Expanded the company through acquisition CathLab, Inc of Irvine California, a related revenue-producing company in 1993.  As Chairman and CEO I managed over 70 employees operating a GMP state-of-the-art facility. I acquired two companies after the IPO and was able to obtain FDA approval of several products during that period. The company was sold to a private concern in 1996.  

​

1978-1985 ForeRank, Inc. (Professional Engineering Consulting)

ForeRank, Inc. Founded and operated my own Engineering and Consulting company in Houston, Texas.  I negotiated contracts and carried out engineering design, fabrication, and supervision of contracts in the Republic of Panama, Sweden, Denmark, The North Sea (England, Scotland, and Norway) where I utilized my engineering experience for the Petrol-Chemical industry.  My clients were The Northern Company, Republic of Panama, Morrison-Knudsen, Inc, Chevron, British Petroleum, Texaco, SkandiaGas, (Sweden) and Scottish Marine Oil Company. I was successful in completing of the Trans-Panama Pipeline with Super Tanker mooring and loading facilities, and the Trans-Orsand Straits pipeline from Malmo, Sweden to Copenhagen, Denmark.

 

1973-1978 Louisiana Offshore Oil Port (Loop, Inc.) Chief Construction Manager

Served as a Marine Engineer and Construction Manager for the $3 billion off-shore supertanker loading facility off New Orleans in the Gulf of Mexico. During construction, I oversaw both fabrication and construction of operational facilities, loading on sea-going barges, subsea pipelines, and deep-sea placement of platforms and single point mooring (3) buoys for supertanker off-loading. Once completed, I oversaw the check-out and start-up of operations. My responsibilities included all trade and craft labor, divers, service vessels, hospitality, and catering for the platform.  This was the first supertanker loading and pipeline for the Strategic Oil Reserve built by the United States.

 

1965-1973 C.R. Bard, Inc. (NYSE-BRD) Division Manager

C.R.Bard, Inc., a major medical device and drug company, where I began as a field sales representative and rose to the middle management position of Division Manager supervising 12 sales reps in 8 mid-western states with P&L responsibility for $10 million in annual sales.  C.R. Bard is an $800 million company located in Murray Hill, N.J. specializing in urological and cardiovascular products. I was salesman-of-the-year in l966 and 1967 before being promoted to P&L responsibilities of Mid-West Division Manager in 1969-1973.

 

1962-1965 KBR-Halliburton Marine Construction Specialist

Marine Engineer and Construction specialist on offshore drilling and production facilities in the Gulf of Mexico and the Gulf of Paria Venezuela. As a 21 year-old apprentice, I apprenticed on all crafts. I advanced to “journeyman” status as a pipefitter, welder, and rigger. I supervised a crew of ironworkers, electricians, pipefitters, rotating machinery specialists, millwrights, and electrical engineers that assembled, erected, and commissioned all aspects of petroleum drilling, production, and petroleum transportation.

​

Education: 

 

Doctor of Philosophy (Ph.D., Economics), Kennedy Western University, 1991

Master of Business Administration (MBA) Pepperdine University, 1980

The University of Houston, Physics (changed to) Structural Engineering, 1962-65 

(left in 1965 to pursue a booming, high paying career in the Oil and Gas Industry)

​

Affiliations:

 

Fellow, American College of Angiology; (FACA) Fellow for over 30 years, American Society of Thrombosis and Blood Diseases, (Fellow, ASTBD)

Fellow, International Society of Endovascular Specialist;

Member, (F, ISES) Society of Cardiovascular and Interventional Radiology; (SCIVR)

Member, New York Academy of Sciences;( NYAS)

Member Society of Plastic Engineers, (SPE)

Member, European Society for Vascular Medicine, (ESVS)

Member, College of Physician Inventors; (CPI)

Member, Houston Inventors Society, (HIS)

 

Papers, Presentations, Patents & Trademarks, and Patents Pending:

 

During the past 20 years, I have written and received grants for NIH, grants from industry, presented papers, abstracts, guest lectures, and sat on expert panels at various symposiums, scientific meetings, and other professional meetings including Society of Plastic Engineers, TransCatheter Therapeutics Society, American College of Angiology, Liposome Society, European Heart Society, and the American Heart Association. 

 

Over the past 30 years I have authored over  50 U.S. and foreign patents, including urinary-catheters first patent in (1971), catheter valves, coatings, incontinency valves for both male and females, industrial quick coupling devices, mechanical heart assist devices, (2), special catheters, drug delivery catheters, drug delivery liposomes, self-everting catheters, vascular stents, stent coatings, and drug formulations. (list available on request). 

 

Currently, I have three new patent applications for improvements to Liprostin™ assigned to Angiomedx. They are: SUMM/510PROV application has been assigned serial no. 61/767,231 and the SUMM/510PROV2 application has been assigned serial no. 61/767,238. The filing date for both applications is February 20, 2013, and Summ/ 515, US Ser. No. 09/10, 02.

​

Personal Comments: I am a consummate inventor and entrepreneur with a life-long career in science and medicine.  I consider medicine to be both a science and an art and have a passion for finding the simple out of the complex, otherwise known as “order out of chaos.”  I believe that each person has within himself the innate creativity to make reality from anything that can be imagined. However, I have come to know that commerce makes any discovery viable and without the entrepreneurial component, no new discovery will ever see the light of day and subsequently be of benefit to my fellow man. Finally, my philosophy is; “there are no problems without solutions on the face of the earth!”

Dr. David P. Summers, PhD, FACA

14001 Walden Rd. Ste 600, Montgomery, TX 77356

Email: dpsummers@outlook.com Tele:  936.520.3606